Reference values for PCDD/Fs and dioxin-like PCBs in serum were recently published based on the WHO 1998 TEFs and NHANES data. In 2006, the World Health Organization (WHO) revised toxic equivalency factors (TEFs) for a number of congeners. In accordance with these changes, we calculated new reference statistics using the WHO 2006 TEFs. Additionally, the contribution of individual congeners to the total TCDD TEQ and the effect that the revised TEFs had on total TEQ serum concentrations for the general U.S. population were also determined. All 2,3,7,8-substituted PCDD/F and nine dioxin-like PCB serum concentration data examined in this study are from the 2001–2002 NHANES survey. Total TCDD TEQ for each individual volunteer was calculated by summing the product of each congener's concentration and the associated 2006 WHO TEF. Calculation of reference values and all statistical analyses were conducted using SAS and SUDAAN software. 2,3,7,8-TCDD, 1,2,3,7,8-PeCDD, 1,2,3,6,7,8-HxCDD, 2,3,4,7,8-PeCDF, and PCB 126 still contributed the greatest percentage to the total TEQ. However, both PCBs 156 and 157 were no longer significant contributors, instead being displaced by 1,2,3,4,7,8-HxCDF and PCB 169. Using the new TEF scheme, TEQ 17–9 was approximately equal to TEQ 17–3 . Average total TEQ estimates were 5–12 ppt lower than average estimates calculated using the WHO 1998 TEFs, and 95 th percentile estimates were reduced by 5 to 25 ppt with the largest reductions in total TEQ for older individuals. The updated TEFs had little impact on the percent contribution of the dioxin, furan, and co-planar PCB congeners to the total TEQ. However, the decrease in TEFs for the mono- ortho substituted PCBs decreased their contribution to total TEQ appreciably as well as reduced estimates of total TEQ body burden.